Ramesh Palaparthy

Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925

Ariel Graff‐Guerrero, Laura Redden, Walid Abi‐Saab et al. · The International Journal of Neuropsychopharmacology · 2009 · 66 citations

Medicine, Neuroscience, Pharmacology +14

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy

Stanley Cohen, Rieke Alten, Hideto Kameda et al. · Arthritis Research & Therapy · 2018 · 59 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study

Vamshi Jogiraju, Jenna Yager, John Ling et al. · The Lancet · 2025 · 44 citations

Medicine, Pharmacokinetics, Pharmacology +7

A study of the pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed pregnant women with HIV

Haeyoung Zhang, Jason T. Hindman, Ludwig H. Lin et al. · AIDS · 2023 · 34 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

A randomized study comparing the pharmacokinetics of the potential biosimilar PF-06438179/GP1111 with Remicade® (infliximab) in healthy subjects (REFLECTIONS B537-01)

Ramesh Palaparthy, Chandrasekhar Udata, Steven Y. Hua et al. · Expert Review of Clinical Immunology · 2018 · 25 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +10